Your browser doesn't support javascript.
loading
Parathyroid hormone-related protein (PTHrP) and malignancy.
Grunbaum, Ami; Kremer, Richard.
Afiliação
  • Grunbaum A; Calcium Research Laboratories and Department of Medicine, McGill University and McGill University Health Centre, Montreal, QC, Canada.
  • Kremer R; Calcium Research Laboratories and Department of Medicine, McGill University and McGill University Health Centre, Montreal, QC, Canada. Electronic address: richard.kremer@mcgill.ca.
Vitam Horm ; 120: 133-177, 2022.
Article em En | MEDLINE | ID: mdl-35953108
ABSTRACT
PTHrP (parathyroid hormone related protein) is an important mediator of malignancy-related tumor progression and hypercalcemia that shares considerable homology and functionality with parathyroid hormone. In this chapter, we review what has been elucidated to date regarding PTHrP's role in malignancies. Starting with a review of calcium metabolism and regulation, we then summarize the discovery and structure of PTHrP and development of sensitive immunoassays for specific measurement. Subsequently, we explore its role in tumor progression, with emphasis on the primary tumor as well as skeletal and non-osseus metastases. We then consider the clinical implications of PTHrP in cancer before concluding with a discussion of both established and potential treatments for malignancy associated hypercalcemia and bone metastases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Paraneoplásicas / Neoplasias Ósseas / Hipercalcemia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Paraneoplásicas / Neoplasias Ósseas / Hipercalcemia Idioma: En Ano de publicação: 2022 Tipo de documento: Article